# HC9 Ventures

> HC9 Ventures is a New York-based early-stage venture firm investing in healthcare software and services, primarily at Seed and Series A. Its pitch is less about supplying scarce capital than supplying scarce context: an engaged community of healthcare executives, entrepreneurs, and investors who can help founders sharpen product-market fit, navigate long enterprise sales cycles, and reach payers and providers. Fund I closed at $83 million in 2022, and the firm's public portfolio spans behavioral health, virtual specialty care, medical transport, social care, vision benefits, care transitions, senior primary care, and enterprise healthcare AI.

- **Founded:** 2021
- **Headquarters:** New York, United States
- **Founders:** Richard Lungen (Co-Founder and General Partner), Jon Gordon (Co-Founder and Venture Partner), Charlie Falcone (Co-Founder and General Partner)
- **Team size:** Six investment and operating team members are listed on HC9's website as of August 2026; LinkedIn classifies the firm as having 2-10 employees.
- **Products:** Seed and Series A investment, Operator community support, Portfolio interview series, HC9: The Next Generation
- **Notable:** Closed an $83 million debut fund in November 2022., Assembled an anchor and LP community led by healthcare executives, entrepreneurs, and investors., Reached 10 public portfolio companies by October 2025.

## Products & services

- **Seed and Series A investment** — Equity capital for early-stage U.S. healthcare software and services businesses, especially companies addressing care delivery or payer and provider operations.
- **Operator community support** — Introductions, market insight, board talent, product-market-fit guidance, and go-to-market help from HC9's network of healthcare executives, entrepreneurs, investors, and limited partners.
- **Portfolio interview series** — Public founder and operator conversations about healthcare problems, company-building, customers, competition, and the decision to work with HC9.
- **HC9: The Next Generation** — A career and venture-learning program for 18-to-25-year-olds nominated by HC9 limited partners, including networking, resume, and healthcare-career instruction.

## Achievements

- Closed an $83 million debut fund in November 2022.
- Assembled an anchor and LP community led by healthcare executives, entrepreneurs, and investors.
- Reached 10 public portfolio companies by October 2025.
- Led or co-led financings for XP Health, Laguna Health, Circadian Health, and Reema Health.
- Backed Reema from its 2024 Series A through its $19 million Series B in 2025.
- Continued backing Optura in a $17.5 million Series A in May 2026.
- Built a public interview archive covering every portfolio company from Forge Health to Optura.
- Launched the first in-person HC9: The Next Generation cohort in 2026.

## Latest updates

- **2026-07** — Richard Lungen and Charlie Falcone discussed HC9's operator-led investment model on Bloomberg Intelligence's Vanguards of Healthcare podcast.
- **2026-05** — Optura raised a $17.5 million Series A led by Salesforce Ventures with Echo Health Ventures and continued backing from HC9, Susa Ventures, and Matrix Partners.
- **2026-04** — HC9 published its Q1 2026 round-up, including portfolio milestones, its annual meeting, and the first Next Generation program.
- **2026-01** — HC9 published its tenth portfolio interview, featuring healthcare AI orchestration company Optura.
- **2025-12** — Reema Health raised a $19 million Series B from LRVHealth and Optum Ventures with follow-on investment from HC9.
- **2025-10** — HC9 announced its tenth public investment and first investment in what it calls the return-on-AI-investment category.

## Links

- Website: https://hc9.vc
- LinkedIn: https://www.linkedin.com/company/hc9-ventures

---

Profile page: https://yespress.io/hc9-ventures
Published by YesPress — https://yespress.io
Last updated: 2026-08-15